Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pathophysiology
100%
Classical Type
100%
Hidradenitis Suppurativa
100%
Type I Interferon
100%
IFN Response
15%
Functional Impact
15%
Inflammation
15%
Skin Lesions
7%
Specific Intent
7%
Scar
7%
Therapeutic Approaches
7%
Therapeutic Potential
7%
Immune Infiltration
7%
Infection Events
7%
Subtype-specific
7%
Clinical Trials
7%
Signaling Mechanism
7%
Keratinocytes
7%
Tissue Disruption
7%
Skinfolds
7%
RNA Sequencing (RNA-seq)
7%
Interleukin-17 (IL-17)
7%
Future Therapeutics
7%
Hair Follicle
7%
Inflammatory Skin Diseases
7%
Intestinal Tissue
7%
JAK-STAT
7%
Nasopharyngeal
7%
Skin Function
7%
Black Box Warning
7%
Cardiovascular Events
7%
Epidermal Hyperplasia
7%
Epithelial Cells
7%
Adverse Events
7%
FDA-approved Drugs
7%
Female Reproductive Tract
7%
Cytokine Profile
7%
Cell Complex
7%
EGFR Ligands
7%
IFN Signaling
7%
Lung Tissue
7%
Successful Completion
7%
Drug Carries
7%
Unique Mechanism
7%
Novel Therapeutics
7%
Debilitating Disease
7%
Medicine and Dentistry
Interferon Type I
100%
Pathophysiology
100%
Hidradenitis Suppurativa
100%
Infection
15%
Skin Defect
7%
Signaling Mechanism
7%
Cardiovascular System
7%
Epithelial Cell
7%
Lung
7%
RNA Sequencing
7%
Epidermal Growth Factor Receptor
7%
Scar Formation
7%
Keratinocyte
7%
Tumor Necrosis Factor
7%
Adverse Event
7%
Cytokine
7%
Dermatitis
7%
Diseases
7%
Immunocompetent Cell
7%
Epidermis Hyperplasia
7%
Hair Follicle
7%
Skinfold
7%
Cellular Infiltration
7%
Clinical Trial
7%
Female Reproductive Tract
7%
Pharmacology, Toxicology and Pharmaceutical Science
Pathophysiology
100%
Interferon Type I
100%
Suppurative Hidradenitis
100%
Infection
15%
Inflammation
15%
Skin Defect
7%
Epidermal Growth Factor Receptor
7%
Janus Kinase Inhibitor
7%
Dermatitis
7%
Cytokine
7%
Adverse Event
7%
Diseases
7%
Clinical Trial
7%
Epidermis Hyperplasia
7%
Tumor Necrosis Factor
7%
Scar Formation
7%